Rx drug information, pharmaceutical research, clinical trials, news, and more
[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. [2010.11]
[Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product] [2007.06]
Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. [2006.08]
Time course of changes in ocular aberrations after instillation of carteolol long-acting solution and timolol gel-forming solution. [2011.04]
Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. [2010.03.15]
Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma. [2010.03]
[The influence of carteolol and pentoxyphylin on the visual field in glaucoma patients--case reports of selected patients] [2010.02]
[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. [Article in Japanese] [2010]
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. [2007]
Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. [2006.01]
Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage. [2005.11]
[Toxic effects of medications on the cornea] [2007]
Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma. [2008.04]
Designing dendrimers for ocular drug delivery. [2010.01]
[Retrospective analysis of clinical characteristics of toxic anterior segment syndrome]. [2009.03]
Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. [2009.11]
All Rights reserved - Copyright DrugLib.com, 2006-2017